4
Changes in Ownership
Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-19-055941
Chief Executive Officer bought 1,430 shares at $4.26 ($6,092)
From the SEC's structured data for this filing
Trades in this filing
Cohen Yuval · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-11-12 | Purchase : show line 1 in the form | +1,430 | $4.26 | $6,092 | 66,790 | D |
| Open-market purchases · 1,430 sh · avg $4.26 · $6,092 | ||||||
Loading xslF345X03/doc4.xml…